Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mission LISA (Learning Indicators of Substance Addiction) is a data-driven research foundation and initiative launched by Lumina Analytics to address the United States opioid epidemic. The organization utilizes artificial intelligence and deep web mining to aggregate and analyze massive amounts of public data, providing real-time intelligence and evidence-based policy recommendations to healthcare providers and policymakers. Mission LISA focuses on identifying disparities in federal funding, improving treatment pathways for non-fatal overdoses, and quantifying the true scope of the crisis through advanced data analytics. By leveraging machine learning, the foundation aims to provide a more accurate and timely understanding of addiction prevalence to optimize resource allocation and crisis mitigation efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mission LISA.